Optical Biosystems, Inc. announced that it has received $20 million in funding from a group of investors
November 18, 2020
Share
Optical Biosystems, Inc. announced that it has received $20,000,000 in a round of funding led by new investor Illumina Ventures on November 19, 2020. The transaction included participation from Lifecore Partners, NCORE VENTURES, Xolon Invest Co., Ltd., CTK Investments Ltd., Ray Co., Ltd. (KOSDAQ:A228670), Seegene Medical Foundation, Timefolio Asset Management Co.,Ltd, and LabGenomics Co., Ltd. (KOSDAQ:A084650)
Ray Co.,Ltd is a Korea-based company mainly engaged in the development, production and distribution of dental imaging medical devices. Along with its subsidiaries, the Company manufactures and sells digital diagnostic systems and digital therapy solution products. Digital diagnostic systems include dental radiography equipments such as x-ray systems and cone beam computed tomography (CBCT) systems. Digital therapy solutions include three dimensional (3D) scanning, dental computer aided design (CAD), and 3D printers used in prosthodontics, orthodontics, and implant surgery. The Company distributes its products within domestic market and to overseas markets.
RAY CO., LTD. 
